For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say
June 30, 2023 at 13:28 PM EDT
Lower-price biosimilar competition for top-selling drug launching this weekend.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.